iGarden Opens Pre-Sale for Swim Jet P Series -- The Perfect Swim Jet for Home Pool Fun
LOS ANGELES, Nov. 2, 2025 /PRNewswire/ -- iGarden, the visionary sub-brand of Fairland Group based on the philosophy of Artful Living Technology-focused on innovative backyard solutions, announced the official pre-sale launch of its Swim Jet P...
SuperX Reports Annual Financial Results for FY2025; Sets Stage for AI Infrastructure Growth in FY2026
FY2025 Results Reflect Legacy Operations; Major Post-Year-End Milestones Lay Foundation for Next-Phase Expansion SINGAPORE, Nov. 1, 2025 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX) ("SuperX" or "the Company"), formerly Super X AI...
ECARX Secured up to $150 Million to Advance Strategic Growth Initiatives and Strengthen Liquidity
LONDON, Nov. 1, 2025 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility technology provider, today announced that it had entered into a securities purchase agreement (the "Transaction") with ATW Partners,...
Boqii Holding Limited Provides Response to Unusual Market Action
SHANGHAI, Nov. 1, 2025 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ), a leading pet-focused platform in China, announced today that the Company had become aware of unusual trading activity in its Class A...
THE MARK HOTEL CELEBRATED IN THE WORLD'S 50 BEST HOTELS 2025 PRESTIGIOUS RANKING
Celebrating innovation, excellence, and transformative travel experiences worldwide NEW YORK, Oct. 31, 2025 /PRNewswire/ -- The Mark Hotel is the only hotel in New York City, and one of only two hotels in the entire United States, named on the...
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial.
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic lateral sclerosis (ALS) has officially initiated...
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naive patients with differentiated thyroid cancer – TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka;...
SilentSwap V2 Launch Sets New Standard for Institutional Blockchain Privacy Infrastructure
SilentSwap V2 introduces a privacy-focused infrastructure designed for organizations deploying blockchain technology. Recognizing that over 70% of institutions cite privacy as a major barrier to adoption, SilentSwap V2 addresses transparency risks...
AI Semiconductor Innovator DEEPX Recognized by NYSE and WEF
The Leading Player in On-Device AI Is Realizing the Physical AI Era While Drawing Wall Street's Attention NEW YORK, Oct. 31, 2025 /PRNewswire/ -- As AI begins to sustainably generate tangible value, global AI semiconductor innovator DEEPX (CEO...
Elevaris Medical Devices Names New Chief Engineering and Operations Officer
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the appointment of its new Chief Engineering and Operations...